Medical abortion practices: a survey of National Abortion Federation members in the United States

Contraception

Volumn 78, Issue 6, 2008, Pages 486-491

  Wiegerinck, Melanie M J ^a   Jones, Heidi E ^b   O'Connell, Katharine ^b   Lichtenberg, E Steve ^c   Paul, Maureen ^d   Westhoff, Carolyn L ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NewYork Presbyterian Hospital   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Abortion; First trimester abortion; Medical abortion; Mifepristone; United States

Indexed keywords

COCODAMOL; METHOTREXATE; MIFEPRISTONE; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CLINICAL PRACTICE; CLINICAL PROTOCOL; DRUG APPROVAL; DRUG UTILIZATION; EVIDENCE BASED PRACTICE; FIRST TRIMESTER PREGNANCY; FOOD AND DRUG ADMINISTRATION; HEALTH CARE FACILITY; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; MEDICAL ABORTION; NATIONAL ABORTION FEDERATION; NORMAL HUMAN; PRACTICE GUIDELINE; QUESTIONNAIRE; UNITED STATES;

ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ABORTION, LEGAL; AMBULATORY CARE FACILITIES; FEMALE; HEALTH CARE SURVEYS; HUMANS; MIFEPRISTONE; MISOPROSTOL; PHYSICIAN'S PRACTICE PATTERNS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; QUESTIONNAIRES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 56149088377     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2008.07.015     Document Type: Article

References (23)

1. Jones R.K., Zolna M.R.S., Henshaw S.K., and Finer L.B. Abortion in the United States: incidence and access to services, 2005. Perspect Sex Reprod Health 40 (2008) 6-16
2. Kulier R., Gulmezoglu A.M., Hofmeyr G.J., Cheng L.N., and Campana A. Medical methods for first trimester abortion. Cochrane Database Syst Rev (2004) CD002855
3. Gynuity Health Projects. Mifeprisone approval. http://www.gynuity.org/documents/mife_approval_2007_list.pdf, updated 3/12/08. Accessed on June 12, 2008.
4. Jones R.K., and Henshaw S.K. Mifepristone for early medical abortion: experiences in France, Great Britain and Sweden. Perspect Sex Reprod Health 34 (2002) 154-161
5. Boonstra H. Mifepristone in the United States: status and future. Guttmacher Rep Public Policy 5 3 (2002) 4-7
6. O'Connell K., Jones H.E., Lichtenberg E.S., and Paul M. Second trimester surgical abortion practices: a survey of National Abortion Federation members. Contraception 78 (2008) 492-499
7. Lichtenberg E.S., Paul M., and Jones H. First trimester surgical abortion practices: a survey of National Abortion Federation members. Contraception 64 (2001) 345-352
8. World Health Organisation Task Force on Post-Ovulatory Methods of Fertility Regulation. Termination of pregnancy with reduced doses of mifepristone. BMJ 307 (1993) 532-537
9. World Health Organisation Task. Force on Post-Ovulatory Methods of Fertility Regulation. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial. BJOG 107 (2000) 524-530
10. McKinley C., Thong K.J., and Baird D.T. The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol. Hum Reprod 8 (1993) 1502-1505
11. Christin-Maitre S.B.P., and Spitz I.M. Medical termination of pregnancy. N Engl J Med 342 (2000) 946-956
12. Ashok P.W., Penney G.C., Flett G.M., and Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod 13 (1998) 2962-2965
13. Newhall E.P., and Winikoff B. Abortion with mifepristone and misoprostol: regimens, efficacy, acceptability and future directions. Am J Obstet Gynecol 183 (2000) S44-S53
14. El-Refaey H., Rajasekar D., Abdalla M., Calder L., and Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 332 (1995) 983-987
15. Creinin M.D., and Darney P.D. Methotrexate and misoprostol for early abortion. Contraception 48 (1993) 339-348
16. Creinin M.D. Medical abortion regimens: historical context and overview. Am J Obstet Gynecol 183 (2000) S3-S9
17. Clark W.H., Gold M., Grossman D., and Winikoff B. Can mifepristone medical abortion be simplified? A review of the evidence and questions for future research. Contraception 75 (2007) 245-250
18. Fielding S.L., Schaff E.A., and Nam N.Y. Clinicians' perception of sonogram indication for mifepristone abortion up to 63 days. Contraception 66 (2002) 27-31
19. Parashar P., Iversen O.E., Midboe G., Myking O., and Bjorge L. Medical abortion in the first trimester: the use of serum hCG and endometrial thickness as markers of completeness. Eur J Contracept Reprod Health Care 12 (2007) 366-371
20. Godfrey E.M., Anderson A., Fielding S.L., Meyn L., and Creinin M.D. Clinical utility of urine pregnancy assays to determine medical abortion outcome is limited. Contraception 75 (2007) 378-382
21. NAF: Early options; Complications of medical abortion. http://www.prochoice.org/education/cme/online_cme/m2complications.asp. Accessed on May 28, 2008
22. Clark W., Shannon C., and Winikoff B. Misoprostol for uterine evacuation in induced abortion and pregnancy failure. Expert Rev Obstet Gynecol 2 (2007) 67-108
23. Reeves M.F., Kudva A., and Creinin M.D. Medical abortion outcomes after a second dose of misoprostol for persistent gestational sac. Contraception 78 (2008) 332-335